P

Inventor

SKOLNICK PHIL

US15 patents
⚠️ This page may combine multiple inventors who share the name “SKOLNICK PHIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEUROVANCE INC

4 patents
US9737506B2Aug 22, 2017

1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders

NEUROVANCE INC5 citations82
US9205074B2Dec 8, 2015

1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders

NEUROVANCE INC9 citations82
US8877798B2Nov 4, 2014

1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders

NEUROVANCE INC11 citations82
US9133159B2Sep 15, 2015

1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments

NEUROVANCE INC1 citations51

US HEALTH

2 patents
US5086072AFeb 4, 1992

Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex

US HEALTH121 citations94
US6017957AJan 25, 2000

Partial agonists of the strychnine insensitive glycine modulatory site of the N-methyl-D-aspartate receptor complex as neuropsychopharmacological agents

US HEALTH20 citations84

US ARMY

2 patents
US5280015AJan 18, 1994

2-substituted adenosines and 2-substituted adenosine 5'-carboxamides

US ARMY30 citations92
US5428069AJun 27, 1995

Treating cognition with, aminocyclopropanecarboxylic derivatives

US ARMY27 citations85

SKOLNICK PHIL

2 patents
US8461196B2Jun 11, 2013

1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders

SKOLNICK PHIL12 citations89
US8138377B2Mar 20, 2012

Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use

SKOLNICK PHIL5 citations60

U S OF AMERICA

1 patent
US4239744ADec 16, 1980

Radioreceptor assay for benzodiazepines in plasma and other biological specimens

U S OF AMERICA7 citations73

OTSUKA AMERICA PHARMACEUTICAL INC

1 patent
US10039746B2Aug 7, 2018

1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders

OTSUKA AMERICA PHARMACEUTICAL INC3 citations71

OPIANT PHARMACEUTICALS INC

1 patent
US11471437B2Oct 18, 2022

Compositions and methods for treating cannabinoid hyperemesis syndrome with a cannabinoid receptor antagonist

OPIANT PHARMACEUTICALS INC0 citations60

EUTHYMICS BIOSCIENCE INC

1 patent
US9597315B2Mar 21, 2017

1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments

EUTHYMICS BIOSCIENCE INC0 citations51

INDIVIOR INC

1 patent
US12290596B2May 6, 2025

Compositions and methods for the treatment of opioid overdose

INDIVIOR INC0 citations37